Literature DB >> 11817598

An Israeli Arab patient with a de novo TNFRSF1A mutation causing tumor necrosis factor receptor-associated periodic syndrome.

Ebun Aganna1, Avraham Zeharia, Graham A Hitman, Lina Basel-Vanagaite, Rebecca A Allotey, David R Booth, Philip N Hawkins, Catherine Thacker, Denise Syndercombe-Court, Michael F McDermott.   

Abstract

OBJECTIVE: To investigate genetic susceptibility to recurrent fevers, generalized severe myalgia, and migratory erythema in an Israeli Arab child with no family history of similar disease.
METHODS: DNA sequencing of exons 1-6 of the TNFRSF1A gene (formerly TNFR1) was performed in the patient and his parents to determine the presence of the autosomal-dominant tumor necrosis factor receptor-associated periodic syndrome (TRAPS); informative markers spanning the TNFRSF1A locus were used to genotype all available members of the patient's family. The TNFRSF1A gene was subsequently screened in 69 healthy Arab controls and 96 Caucasian controls. Formal forensic paternity testing was performed on the child.
RESULTS: We found a de novo missense mutation in exon 3 of the TNFRSF1A gene, involving a novel C-->T transition encoding a Cys70Arg (C70R) variant, in the Israeli Arab patient. Eight of the common familial Mediterranean fever (FMF) gene MEFV mutations were excluded. This mutation was not present in the parents or siblings, or among the 69 healthy Arab controls. However, another TNFRSF1A variant, Pro46Lys (P46L), was present in 1 of the Arab controls.
CONCLUSION: We have identified a TNFRSF1A mutation associated with periodic fever in an Arab patient, and a TNFRSF1A variant, which is variably pathogenic in Caucasians, in an Arab control. This is the first report of a de novo mutation in periodic fevers in general, and also of TRAPS in the Arab population. These findings demonstrate the need to include TRAPS in the differential diagnosis of recurrent fevers in this population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11817598     DOI: 10.1002/1529-0131(200201)46:1<245::AID-ART10038>3.0.CO;2-6

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

1.  Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept.

Authors:  P D Arkwright; M F McDermott; S M Houten; J Frenkel; H R Waterham; E Aganna; L J Hammond; R M Mirakian; P I Tomlin; P I Vijaydurai; A J Cant
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

2.  Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.

Authors:  Ian Todd; Paul M Radford; Kelly-Ann Draper-Morgan; Richard McIntosh; Susan Bainbridge; Peter Dickinson; Lama Jamhawi; Marios Sansaridis; Mary L Huggins; Patrick J Tighe; Richard J Powell
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

3.  Tumour necrosis factor receptor-associated periodic syndrome with a novel mutation in the TNFRSF1A gene in a Japanese family.

Authors:  Koichi Kusuhara; Akihiko Nomura; Futoshi Nakao; Toshiro Hara
Journal:  Eur J Pediatr       Date:  2003-11-11       Impact factor: 3.183

Review 4.  Falling into TRAPS--receptor misfolding in the TNF receptor 1-associated periodic fever syndrome.

Authors:  Fiona C Kimberley; Adrian A Lobito; Richard M Siegel; Gavin R Screaton
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.